米国の心血管インターベンション（2020年～2026年）COVID-19の影響：MedSuite

米国の心血管インターベンショナルデバイスの市場規模は、2019年に約32億米ドルとなりました。同市場は、予測期間中に3.6％のCAGRで成長する見通しで、2026年には41億米ドルに達すると予測されています。

他の医療機器市場と同様に、心血管インターベンショナル市場は近年統合の時期を経験しています。大規模な競合の市場参入や、戦略的な合併や買収による新しいセグメントへの参入によりリーチを拡大しています。最近の調査によると、ヘルスケア専門家の4分の1が、ヘルスケア業界の統合が2019年の主な動向であると考えています。

当レポートは、米国の心血管インターベンショナルデバイス市場について調査しており、市場の動向や予測、COVID-19の影響、成長および抑制要因、製品別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

図のリスト

チャートのリスト

エグゼクティブサマリー

米国の市場概要

競合分析

動向

市場の進展

手術件数

調査対象の手術コード

市場範囲

主なレポートの更新

バージョン履歴

調査手法

疾患の概要

• 基本的な解剖学
• 治療と診断
  • 一般的な診断
  • 冠状動脈疾患（CAD）
  • 心筋梗塞（MI）
  • 狭心症
• 患者の人口統計
  • 一般的な統計

製品評価

• イントロダクション
• 製品ポートフォリオ
  • 冠状動脈ステント
  • 冠状動脈バルーンカテーテル
  • バルーンインフレデバイス
  • インターベンショナル冠動脈カテーテル
  • インターベンショナル冠状動脈ガイドワイヤー
  • 冠状動脈塞栓保護デバイス
  • 冠状動脈粥腫切除デバイス
  • 冠状動脈血栓摘出デバイス
  • 冠状動脈慢性完全閉塞デバイス
  • 冠状動脈イントロデューサーシース
  • 冠状血管閉鎖デバイス
  • 診断用冠動脈カテーテルおよびガイドワイヤー
  • 冠状血管内超音波
  • 光コヒーレンストモグラフィー
  • 止血バルブ
• 規制上の問題とリコール
  • Abbott
  • Boston Scientific
  • Cardinal Health
  • Medtronic
  • Merit Medical Systems
  • Terumo
• 臨床試験
  • 冠状動脈ステント
  • 冠状動脈バルーンカテーテル
  • バルーン膨張デバイス
  • インターベンショナル冠動脈カテーテル
  • 冠状動脈塞栓保護デバイス
  • 冠状動脈粥腫切除デバイス
  • 冠状血管閉鎖デバイス
  • 冠状血管内超デバイス
  • 冠状動脈光コヒーレンス断層撮影

米国の市場概要

• イントロダクション
• 市場概要
• セグメント別の動向分析
• 成長要因と抑制要因
  • 市場の成長要因
  • 市場の抑制要因
• 競合市場シェア分析
• 合併と買収
• 企業プロファイル
  • Abbott
  • Asahi Intecc
  • Boston Scientific
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Cook Medical
  • Medtronic
  • Merit Medical Systems
  • Penumbra
  • Philips
  • Teleflex
  • Terumo
• SWOT分析
  • Abbott
  • Asahi Intecc
  • Boston Scientific
  • Cardinal Health
  • Cardiovascular Systems Inc.
  • Cook Medical
  • Medtronic
  • Merit Medical Systems
  • Penumbra
  • Philips
  • Teleflex
  • Terumo

COVID-19の影響

• イントロダクション
• マルチシナリオ分析

手術件数

• イントロダクション
• 手術の概要
  • 血管造影
  • 血管形成術/PCI
  • 冠状動脈粥腫切除
  • カテーテル法

冠状動脈ステント市場

• イントロダクション
• 市場概要
• 市場分析と予測
  • 総冠動脈ステント
  • ベアメタルステント
  • 薬剤溶出性ステント
  • 対象ステント
  • 分岐ステント
• ユニット分析
  • 直径別冠状動脈ステントユニット
  • 長さ別冠状動脈ステントユニット
• 成長要因と抑制要因
  • 市場の成長要因
  • 市場の抑制要因
• 競合市場シェア分析

冠状動脈バルーンカテーテル市場

バルーンインフレデバイス市場

インターベンショナル冠動脈カテーテル市場

インターベンショナルコロナリーガイド市場

LIST OF CHARTS

• Chart 1 1: Interventional Cardiology Device Market by Segment, U.S., 2016 - 2026
• Chart 1 2: Interventional Cardiology Device Market Overview, U.S., 2019 & 2026
• Chart 4 1: Interventional Cardiology Device Market by Segment, U.S., 2016 - 2026
• Chart 4 2: Interventional Cardiology Device Market Breakdown, U.S., 2019
• Chart 4 3: Interventional Cardiology Device Market Breakdown, U.S., 2026
• Chart 4 4: Growth Rates by Segment, Interventional Cardiology Device Market, U.S., 2017 - 2026
• Chart 4 5: Leading Competitors, Interventional Cardiology Device Market, U.S., 2019
• Chart 6 1: Interventional Cardiology Device Procedures by Segment, U.S., 2016 - 2026
• Chart 6 2: Angiography Procedures, U.S., 2016 - 2026
• Chart 6 3: Angiography Procedures by Approach, U.S., 2016 - 2026
• Chart 6 4: Angiography Procedures by Setting, U.S., 2016 - 2026
• Chart 6 5: Angioplasty/PCI Procedures, U.S., 2016 - 2026
• Chart 6 6: Angiography/PCI Procedures by Approach, U.S., 2016 - 2026
• Chart 6 7: Angiography/PCI Procedures by Modality, U.S., 2016 - 2026
• Chart 6 8: Angioplasty/PCI Procedures by Setting, U.S., 2016 - 2026
• Chart 6 9: Coronary Atherectomy Procedures, U.S., 2016 - 2026
• Chart 6 10: Catheterization Procedures, U.S., 2016 - 2026
• Chart 7 1: Coronary Stent Market by Segment, U.S., 2016 - 2026
• Chart 7 2: Coronary Stent Market Breakdown, U.S., 2019
• Chart 7 3: Coronary Stent Market Breakdown, U.S., 2026
• Chart 7 4: Total Coronary Stent Market, U.S., 2016 - 2026
• Chart 7 5: Bare-Metal Stent Market, U.S., 2016 - 2026
• Chart 7 6: Drug-Eluting Stent Market, U.S., 2016 - 2026
• Chart 7 7: Covered Stent Market, U.S., 2016 - 2026
• Chart 7 8: Bifurcated Stent Market, U.S., 2016 - 2026
• Chart 7 9: Leading Competitors, Coronary Stent Market, U.S., 2019
• Chart 8 1: Coronary Balloon Catheter Market by Segment, U.S., 2016 - 2026
• Chart 8 2: Coronary Balloon Catheter Market Breakdown, U.S., 2019
• Chart 8 3: Coronary Balloon Catheter Market Breakdown, U.S., 2026
• Chart 8 4: Total Coronary Balloon Catheter Market, U.S., 2016 - 2026
• Chart 8 5: PTCA Balloon Catheter Market, U.S., 2016 - 2026
• Chart 8 6: Total Specialty Balloon Catheter Market, U.S., 2016 - 2026
• Chart 8 7: Cutting Balloon Catheter Market, U.S., 2016 - 2026
• Chart 8 8: Scoring Balloon Catheter Market, U.S., 2016 - 2026
• Chart 8 9: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2019
• Chart 9 1: Balloon-Inflation Device Market, U.S., 2016 - 2026
• Chart 9 2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2019
• Chart 10 1: Interventional Coronary Catheter Market by Segment, U.S., 2016 - 2026
• Chart 10 2: Interventional Coronary Catheter Market Breakdown, U.S., 2019
• Chart 10 3: Interventional Coronary Catheter Market Breakdown, U.S., 2026
• Chart 10 4: Total Interventional Coronary Catheter Market, U.S., 2016 - 2026
• Chart 10 5: Guiding Catheter Market, U.S., 2016 - 2026
• Chart 10 6: Extension Guide Catheter Market, U.S., 2016 - 2026
• Chart 10 7: Micro-Catheter Market, U.S., 2016 - 2026
• Chart 10 8: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2019
• Chart 11 1: Interventional Coronary Guidewire Market, U.S., 2016 - 2026
• Chart 11 2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2019
• Chart 12 1: Coronary Embolic Protection Device Market, U.S., 2016 - 2026
• Chart 12 2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2019
• Chart 13 1: Coronary Atherectomy Device Market by Segment, U.S., 2016 - 2026
• Chart 13 2: Coronary Atherectomy Device Market Breakdown, U.S., 2019
• Chart 13 3: Coronary Atherectomy Device Market Breakdown, U.S., 2026
• Chart 13 4: Total Coronary Atherectomy Device Market, U.S., 2016 - 2026
• Chart 13 5: Mechanical Atherectomy Device Market, U.S., 2016 - 2026
• Chart 13 6: Laser Atherectomy Device Market, U.S., 2016 - 2026
• Chart 13 7: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2019
• Chart 14 1: Coronary Thrombectomy Device Market, U.S., 2016 - 2026
• Chart 14 2: Leading Competitors, Coronary Thrombectomy Device Market, U.S., 2019
• Chart 15 1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2016 - 2026
• Chart 15 2: Coronary Chronic Total Occlusion System Market Breakdown, U.S., 2019
• Chart 15 3: Coronary Chronic Total Occlusion System Market Breakdown, U.S., 2026
• Chart 15 4: CTO Guidewire Market, U.S., 2016 - 2026
• Chart 15 5: CTO Catheter Market, U.S., 2016 - 2026
• Chart 15 6: CTO Device Market, U.S., 2016 - 2026
• Chart 15 7: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2019
• Chart 16 1: Introducer Sheath Market by Segment, U.S., 2016 - 2026
• Chart 16 2: Introducer Sheath Market Breakdown, U.S., 2019
• Chart 16 3: Introducer Sheath Market Breakdown, U.S., 2026
• Chart 16 4: Total Introducer Sheath Market, U.S., 2016 - 2026
• Chart 16 5: Standard Introducer Sheath Market by Segment, U.S., 2016 - 2026
• Chart 16 6: Micro-Introducer Sheath Market, U.S., 2016 - 2026
• Chart 16 7: Introducer Sheath Market by Approach, U.S., 2016 - 2026
• Chart 16 8: Femoral Introducer Sheath Market by Segment, U.S., 2016 - 2026
• Chart 16 9: Radial Introducer Sheath Market, U.S., 2016 - 2026
• Chart 16 10: Leading Competitors, Introducer Sheath Market, U.S., 2019
• Chart 17 1: Coronary Vascular Closure Device Market by Segment, U.S., 2016 - 2026
• Chart 17 2: Coronary Vascular Closure Device Market Breakdown, U.S., 2019
• Chart 17 3: Coronary Vascular Closure Device Market Breakdown, U.S., 2026
• Chart 17 4: Total Coronary Vascular Closure Device Market, U.S., 2016 - 2026
• Chart 17 5: Invasive VCD Market by Segment, U.S., 2016 - 2026
• Chart 17 6: Non-Invasive VCD Market by Segment, U.S., 2016 - 2026
• Chart 17 7: Topical Hemostat Market, U.S., 2016 - 2026
• Chart 17 8: Radial Compression Band Market, U.S., 2016 - 2026
• Chart 17 9: Femoral Compression Band Market, U.S., 2016 - 2026
• Chart 17 10: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2019
• Chart 18 1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2016 - 2026
• Chart 18 2: Diagnostic Coronary Catheter & Guidewire Market Breakdown, U.S., 2019
• Chart 18 3: Diagnostic Coronary Catheter & Guidewire Market Breakdown, U.S., 2026
• Chart 18 4: Diagnostic Coronary Guidewire Market, U.S., 2016 - 2026
• Chart 18 5: Diagnostic Coronary Catheter Market, U.S., 2016 - 2026
• Chart 18 6: FFR Guidewire Market, U.S., 2016 - 2026
• Chart 18 7: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2019
• Chart 19 1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2016 - 2026
• Chart 19 2: Coronary Intravascular Ultrasound Market Breakdown, U.S., 2019
• Chart 19 3: Coronary Intravascular Ultrasound Market Breakdown, U.S., 2026
• Chart 19 4: IVUS Catheter Market, U.S., 2016 - 2026
• Chart 19 5: IVUS Console Market, U.S., 2016 - 2026
• Chart 19 6: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2019
• Chart 20 1: Coronary Optical Coherence Tomography Market, U.S., 2016 - 2026
• Chart 21 1: Hemostasis Valve Market, U.S., 2016 - 2026
• Chart 21 2: Leading Competitors, Hemostasis Valve Market, U.S., 2019

LIST OF FIGURES

• Figure 1 1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2019 (1 of 3)
• Figure 1 2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2019 (2 of 3)
• Figure 1 3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2019 (3 of 3)
• Figure 1 4: Companies Researched in this Report, U.S., 2019
• Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (1 of 3)
• Figure 1 6: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (2 of 3)
• Figure 1 7: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (3 of 3)
• Figure 1 8: Recent Events in the Interventional Cardiology Market, U.S., 2016 - 2026
• Figure 1 9: Interventional Cardiology Device Procedures Covered, U.S.
• Figure 1 10: Procedure Codes Investigated, U.S., 2019
• Figure 1 11: Interventional Cardiology Device Markets Covered, U.S. (1 of 2)
• Figure 1 12: Interventional Cardiology Device Markets Covered, U.S., 2019 (2 of 2)
• Figure 1 13: Key Report Updates
• Figure 1 14: Version History
• Figure 3 1: Coronary Stents by Company
• Figure 3 2: Coronary Balloon Catheters by Company (1 of 2)
• Figure 3 3: Coronary Balloon Catheters by Company (2 of 2)
• Figure 3 4: Balloon-Inflation Devices by Company
• Figure 3 5: Interventional Coronary Catheters by Company (1 of 2)
• Figure 3 6: Interventional Coronary Catheters by Company (2 of 2)
• Figure 3 7: Interventional Coronary Guidewires by Company (1 of 2)
• Figure 3 8: Interventional Coronary Guidewires by Company (2 of 2)
• Figure 3 9: Coronary Embolic Protection Devices by Company
• Figure 3 10: Coronary Atherectomy Devices by Company
• Figure 3 11: Coronary Thrombectomy by Company
• Figure 3 12: Coronary Chronic Total Occlusion Devices by Company
• Figure 3 13: Coronary Introducer Sheaths by Company
• Figure 3 14: Coronary Vascular Closure Devices by Company
• Figure 3 15: Diagnostic Coronary Catheters & Guidewires by Company (1 of 2)
• Figure 3 16: Diagnostic Coronary Catheters & Guidewires by Company (2 of 2)
• Figure 3 17: Coronary Intravascular Ultrasounds by Company
• Figure 3 18: Optical Coherence Tomography by Company
• Figure 3 19: Hemostasis Valves by Company
• Figure 3 20: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm
• Figure 3 21: Class 1 Device Recall NC Trek RX Coronary Dilatation Catheter
• Figure 3 22: Class 1 Device Recall NC TREK Coronary Dilatation Catheter
• Figure 3 23: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter
• Figure 3 24: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS
• Figure 3 25: Class 2 Device Recall StarClose SE Vascular Closure System
• Figure 3 26: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System
• Figure 3 27: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters
• Figure 3 28: Class 2 Device Recall Emerge OverTheWire and Emerge Monorail PTCA Dilatation Catheters
• Figure 3 29: Class 2 Device Recall Encore™ 26 Inflation Device
• Figure 3 30: Class 2 Device Recall Boston Scientific Imager II Angiographic Catheter
• Figure 3 31: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
• Figure 3 32: Class 2 Device Recall Guidezilla II Guide Extension Catheter
• Figure 3 33: Class 2 Device Recall Stingray" Guidewire
• Figure 3 34: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System
• Figure 3 35: Class 2 Device Recall Cordis Precise Nitinol Stent System
• Figure 3 36: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
• Figure 3 37: Class 2 Device Recall Endurant / Endurant II 23mm and 25mm
• Figure 3 38: Class 1 Device Recall Medtronic Confida Expandable Sheath
• Figure 3 39: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter
• Figure 3 40: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter
• Figure 3 41: Class 1 Device Recall 6F Taiga Guiding Catheter
• Figure 3 42: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER
• Figure 3 43: Class 2 Device Recall PreludeEASE
• Figure 3 44: Class 1 Device Recall 7F Prelude Short Sheath Introducer
• Figure 3 45: Class 2 Device Recall Destination Guiding Sheath
• Figure 3 46: Class 2 Device Recall Glidesheath Slender Hydrophilic Coated
• Figure 3 47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System
• Figure 3 48: Class 1 Device Recall Portico Solo ReCollapsible Access System
• Figure 3 49: Class 2 Device Recall AngioSeal Evolution
• Figure 3 50: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)
• Figure 3 51: ILUMIEN IV: OPTIMAL PCI
• Figure 3 52: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)
• Figure 3 53: PROMUS PREMIER™ China Post-Approval Study
• Figure 3 54: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
• Figure 3 55: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
• Figure 3 56: RESOLUTE ONYX Post-Approval Study (ONYX PAS)
• Figure 3 57: A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) (Onyx ONE Clear)
• Figure 3 58: A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)
• Figure 3 59: China Resolute Integrity 34/38 mm Study
• Figure 3 60: RESOLUTE ONYX China Single Arm Study
• Figure 3 61: RESOLUTE ONYX China RCT Study
• Figure 3 62: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
• Figure 3 63: The PREVAIL Study (PREVAIL)
• Figure 3 64: Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation (INFLATION/DE)
• Figure 3 65: Balloon Inflation and Plaque Morphology in Revascularisation (BURST) (BURST)
• Figure 3 66: STOP Persistent AF
• Figure 3 67: ArcticLine Feasibility Study
• Figure 3 68: FIRE AND ICE II Trial Pilot
• Figure 3 69: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First)
• Figure 3 70: Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation (ERUCA)
• Figure 3 71: Neuroprotection in Patients Undergoing Aortic Valve Replacement
• Figure 3 72: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2)
• Figure 3 73: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
• Figure 3 74: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
• Figure 3 75: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s
• Figure 3 76: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD)
• Figure 3 77: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
• Figure 3 78: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)
• Figure 3 79: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trialc
• Figure 3 80: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
• Figure 3 81: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER)
• Figure 3 82: The OPTIMAL Randomized Controlled Trial
• Figure 3 83: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
• Figure 4 1: Interventional Cardiology Device Market by Segment, U.S., 2016 - 2026 (US$M) (1 of 2)
• Figure 4 2: Interventional Cardiology Device Market by Segment, U.S., 2016 - 2026 (US$M) (2 of 2)
• Figure 4 3: Interventional Cardiology Device Market Growth by Segment, U.S., 2016 - 2026 (1 of 2)
• Figure 4 4: Interventional Cardiology Device Market Growth by Segment, U.S., 2016 - 2026 (2 of 2)
• Figure 4 5: Drivers and Limiters, Interventional Cardiology Device Market, U.S., 2019
• Figure 4 6: Leading Competitors, Interventional Cardiology Device Market, U.S., 2019 (1 of 2)
• Figure 4 7: Leading Competitors, Interventional Cardiology Device Market, U.S., 2019 (2 of 2)
• Figure 4 8: SWOT Analysis, Abbott
• Figure 4 9: SWOT Analysis, Asahi Intecc
• Figure 4 10: SWOT Analysis, Boston Scientific
• Figure 4 11: SWOT Analysis, Cardinal Health
• Figure 4 12: SWOT Analysis, Cardiovascular Systems, Inc.
• Figure 4 13: SWOT Analysis, Cook Medical
• Figure 4 14: SWOT Analysis, Medtronic
• Figure 4 15: SWOT Analysis, Merit Medical Systems
• Figure 4 16: SWOT Analysis, Penumbra
• Figure 4 17: SWOT Analysis, Philips
• Figure 4 18: SWOT Analysis, Teleflex
• Figure 4 19: SWOT Analysis, Terumo
• Figure 5 1: Interventional Cardiology Market by Segment, Best Case Scenario, U.S., 2016 - 2026 (US$M) (1 of 2)
• Figure 5 2: Interventional Cardiology Market by Segment, Best Case Scenario, U.S., 2016 - 2026 (US$M) (2 of 2)
• Figure 5 3: Interventional Cardiology Market by Segment, Base Case Scenario, U.S., 2016 - 2026 (US$M) (1 of 2)
• Figure 5 4: Interventional Cardiology Market by Segment, Base Case Scenario, U.S., 2016 - 2026 (US$M) (2 of 2)
• Figure 5 5: Interventional Cardiology Market by Segment, Worst Case Scenario, U.S., 2016 - 2026 (US$M) (1 of 2)
• Figure 5 6: Interventional Cardiology Market by Segment, Worst Case Scenario, U.S., 2016 - 2026 (US$M) (2 of 2)
• Chart 5 7: Multi-Scenario Interventional Cardiology Market, U.S., 2016 - 2026 (US$M)
• Figure 6 1: Procedure Codes Investigated, U.S., 2019
• Figure 6 2: Interventional Cardiology Device Procedures by Segment, U.S., 2016 - 2026
• Figure 6 3: Angiography Procedures, U.S., 2016 - 2026
• Figure 6 4: Angiography Procedures by Approach, U.S., 2016 - 2026
• Figure 6 5: Angiography Procedures by Setting, U.S., 2016 - 2026
• Figure 6 6: Angioplasty/PCI Procedures, U.S., 2016 - 2026
• Figure 6 7: Angioplasty/PCI Procedures by Approach, U.S., 2016 - 2026
• Figure 6 8: Angiography/PCI Procedures by Modality, U.S., 2016 - 2026
• Figure 6 9: Angioplasty/PCI Procedures by Setting, U.S., 2016 - 2026
• Figure 6 10: Angiography/PCI Procedures by Imaging Technique, U.S., 2016 - 2026
• Figure 6 11: Coronary Atherectomy Procedures, U.S., 2016 - 2026
• Figure 6 12: Catheterization Procedures, U.S., 2016 - 2026
• Figure 7 1: Coronary Stent Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 7 2: Total Coronary Stent Market, U.S., 2016 - 2026
• Figure 7 3: Bare-Metal Stent Market, U.S., 2016 - 2026
• Figure 7 4: Drug-Eluting Stent Market, U.S., 2016 - 2026
• Figure 7 5: Covered Stent Market, U.S., 2016 - 2026
• Figure 7 6: Bifurcated Stent Market, U.S., 2016 - 2026
• Figure 7 7: Coronary Stent Units Sold by Diameter, U.S., 2019
• Figure 7 8: Coronary Stent Units Sold by Diameter, U.S., 2019
• Figure 7 9: Drivers and Limiters, Coronary Stent Market, U.S., 2019
• Figure 7 10: Leading Competitors, Coronary Stent Market, U.S., 2019
• Figure 8 1: Coronary Balloon Catheter Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 8 2: Total Coronary Balloon Catheter Market, U.S., 2016 - 2026
• Figure 8 3: PTCA Balloon Catheter Market, U.S., 2016 - 2026
• Figure 8 4: Specialty Balloon Catheter Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 8 5: Total Specialty Balloon Catheter Market, U.S., 2016 - 2026
• Figure 8 6: Cutting Balloon Catheter Market, U.S., 2016 - 2026
• Figure 8 7: Scoring Balloon Catheter Market, U.S., 2016 - 2026
• Figure 8 8: Coronary Balloon Catheter Units Sold by Classification, U.S., 2019
• Figure 8 9: Coronary Balloon Catheter Units Sold by Indication, U.S., 2019
• Figure 8 10: Drivers and Limiters, Coronary Balloon Catheter Market, U.S., 2019
• Figure 8 11: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2019
• Figure 9 1: Balloon-Inflation Device Market, U.S., 2016 - 2026
• Figure 9 2: Drivers and Limiters, Balloon-Inflation Device Market, U.S., 2019
• Figure 9 3: Leading Competitors, Balloon-Inflation Device Market, U.S., 2019
• Figure 10 1: Interventional Coronary Catheter Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 10 2: Total Interventional Coronary Catheter Market, U.S., 2016 - 2026
• Figure 10 3: Guiding Catheter Market, U.S., 2016 - 2026
• Figure 10 4: Extension Guide Catheter Market, U.S., 2016 - 2026
• Figure 10 5: Micro-Catheter Market, U.S., 2016 - 2026
• Figure 10 6: Drivers and Limiters, Interventional Coronary Catheter Market, U.S., 2019
• Figure 10 7: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2019
• Figure 11 1: Interventional Coronary Guidewire Market, U.S., 2016 - 2026
• Figure 11 2: Drivers and Limiters, Interventional Coronary Guidewire Market, U.S., 2019
• Figure 11 3: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2019
• Figure 12 1: Coronary Embolic Protection Device Market, U.S., 2016 - 2026
• Figure 12 2: Drivers and Limiters, Coronary Embolic Protection Device Market, U.S., 2019
• Figure 12 3: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2019
• Figure 13 1: Coronary Atherectomy Device Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 13 2: Total Coronary Atherectomy Device Market, U.S., 2016 - 2026
• Figure 13 3: Mechanical Atherectomy Device Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 13 4: Laser Atherectomy Device Market, U.S., 2016 - 2026
• Figure 13 5: Drivers and Limiters, Coronary Atherectomy Device Market, U.S., 2019
• Figure 13 6: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2019
• Figure 14 1: Coronary Thrombectomy Device Market, U.S., 2016 - 2026
• Figure 14 2: Drivers and Limiters, Coronary Thrombectomy Device Market, U.S., 2019
• Figure 14 3: Leading Competitors, Coronary Thrombectomy Device Market, U.S., 2019
• Figure 15 1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 15 2: CTO Guidewire Market, U.S., 2016 - 2026
• Figure 15 3: CTO Catheter Market, U.S., 2016 - 2026
• Figure 15 4: CTO Device Market, U.S., 2016 - 2026
• Figure 15 5: Drivers and Limiters, Coronary Chronic Total Occlusion System Market, U.S., 2019
• Figure 15 6: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2019
• Figure 16 1: Introducer Sheath Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 16 2: Total Introducer Sheath Market, U.S., 2016 - 2026
• Figure 16 3: Standard Introducer Sheath Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 16 4: Micro-Introducer Sheath Market, U.S., 2016 - 2026
• Figure 16 5: Introducer Sheath Market by Approach, U.S., 2016 - 2026
• Figure 16 6: Femoral Introducer Sheath Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 16 7: Radial Introducer Sheath Market, U.S., 2016 - 2026
• Figure 16 8: Drivers and Limiters, Introducer Sheath Market, U.S., 2019
• Figure 16 9: Leading Competitors, Introducer Sheath Market, U.S., 2019
• Figure 17 1: Coronary Vascular Closure Device Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 17 2: Total Coronary Vascular Closure Device Market, U.S., 2016 - 2026
• Figure 17 3: Invasive VCD Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 17 4: Non-Invasive VCD Market by Segment, U.S., 2016 - 2026
• Figure 17 5: Total Non-Invasive VCD Market, U.S., 2016 - 2026
• Figure 17 6: Topical Hemostat Market, U.S., 2016 - 2026
• Figure 17 7: Radial Compression Band Market, U.S., 2016 - 2026
• Figure 17 8: Femoral Compression Band Market, U.S., 2016 - 2026
• Figure 17 9: Drivers and Limiters, Coronary Vascular Closure Device Market, U.S., 2019
• Figure 17 10: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2019
• Figure 18 1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 18 2: Diagnostic Coronary Guidewire Market, U.S., 2016 - 2026
• Figure 18 3: Diagnostic Coronary Catheter Market, U.S., 2016 - 2026
• Figure 18 4: FFR Guidewire Market, U.S., 2016 - 2026
• Figure 18 5: Penetration Rate, Fractional Flow Reserve Guidewire Market, U.S., 2016 - 2026
• Figure 18 6: Drivers and Limiters, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2019
• Figure 18 7: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2019
• Figure 19 1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2016 - 2026 (US$M)
• Figure 19 2: IVUS Catheter Market, U.S., 2016 - 2026 (US$M)
• Figure 19 3: IVUS Console Market, U.S., 2016 - 2026
• Figure 19 4: Drivers and Limiters, Coronary Intravascular Ultrasound Market, U.S., 2019
• Figure 19 5: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2019
• Figure 20 1: Coronary Optical Coherence Tomography Market, U.S., 2016 - 2026
• Figure 20 2: Coronary Optical Coherence Tomography Penetration, U.S., 2016 - 2026
• Figure 20 3: Drivers and Limiters, Coronary Optical Coherence Tomography Market, U.S., 2019
• Figure 20 4: Leading Competitors, Coronary Optical Coherence Tomography Market, U.S., 2019
• Figure 21 1: Hemostasis Valve Market, U.S., 2016 - 2026
• Figure 21 2: Drivers and Limiters, Hemostasis Valve Market, U.S., 2019
• Figure 21 3: Leading Competitors, Hemostasis Valve Market, U.S., 2019

Throughout this medical market research, iData Research analyzed 43 interventional cardiology device companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the US Interventional Cardiology Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered

• 1. Procedure Volumes for the US Interventional Cardiology Market - MedPro

• 2. Coronary Stent Market - MedCore

• 3. Coronary Balloon Catheter Market - MedCore

• 4. Introducer Sheath Market - MedCore

• 5. Balloon-Inflation Device Market - MedCore

• 6. Interventional Coronary Catheter Market- MedCore

• 7. Interventional Coronary Guidewire Market - MedCore

• 8. Coronary Embolic Protection Device Market - MedCore

• 9. Coronary Atherectomy Device Market - MedCore

• 10. Coronary Thrombectomy Market - MedCore

• 11. Coronary Chronic Total Occlusion (CTO) System Market - MedCore

• 12. Coronary Vascular Closure Device (VCD) Market - MedCore

• 13. Diagnostic Coronary Catheter & Guidewire Market - MedCore

• 14. Coronary Intravascular Ultrasound (IVUS) Market - MedCore

• 15. Coronary Optical Coherency Tomography Market - MedCore

• 16. Hemostasis Valve Market - MedCore

US Interventional Cardiology Device Market Insights

Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019.

Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019.

Overall, the U.S. interventional cardiology device market was valued at approximately $3.2 billion in 2019. This is expected to increase to $4.1 billion by 2026, resulting in a CAGR of 3.6%.

The full report suite on the U.S. market for interventional cardiology devices includes analysis on the coronary stent, coronary balloon catheter, balloon-inflation device, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, coronary atherectomy device, coronary thrombectomy device, chronic total occlusion system, introducer sheath, coronary vascular closure device, diagnostic coronary catheter and guidewire, intravascular ultrasound (IVUS), optical coherence tomography (OCT) and hemostasis valve markets.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

• 2.1 BASIC ANATOMY
• 2.2 DISEASE TREATMENTS AND DIAGNOSTICS
  • 2.2.1 General Diagnostics
  • 2.2.2 Coronary Artery Disease (CAD)
  • 2.2.3 Myocardial Infarction (MI)
  • 2.2.4 Angina Pectoris
• 2.3 PATIENT DEMOGRAPHICS
  • 2.3.1 General Statistics

PRODUCT ASSESSMENT

• 3.1 INTRODUCTION
• 3.2 PRODUCT PORTFOLIOS
  • 3.2.1 Coronary Stent Market
  • 3.2.2 Coronary Balloon Catheter Market
  • 3.2.3 Balloon-Inflation Device Market
  • 3.2.4 Interventional Coronary Catheter Market
  • 3.2.5 Interventional Coronary Guidewire Market
  • 3.2.6 Coronary Embolic Protection Device Market
    • 3.2.6.1 Saphenous Vein Grafts
    • 3.2.6.2 Protection Mechanism
    • 3.2.6.2.1 Filter Basket
    • 3.2.6.2.2 Distal Balloon Occlusion
  • 3.2.7 Coronary Atherectomy Device Market
    • 3.2.7.1 Laser Atherectomy
    • 3.2.7.2 Directional Coronary Atherectomy (DCA)
    • 3.2.7.3 Mechanical Atherectomy
  • 3.2.8 Coronary Thrombectomy Device Market
  • 3.2.9 Coronary Chronic Total Occlusion Device Market
  • 3.2.10 Coronary Introducer Sheath Market
    • 3.2.10.1 Femoral Approach
    • 3.2.10.2 Radial/Brachial Approach
  • 3.2.11 Coronary Vascular Closure Device Market
  • 3.2.12 Diagnostic Coronary Catheter & Guidewire
  • 3.2.13 Coronary Intravascular Ultrasound Market
  • 3.2.14 Optical Coherence Tomography Market
  • 3.2.15 Hemostasis Valve Market
• 3.3 REGULATORY ISSUES AND RECALLS
  • 3.3.1 Abbott
    • 3.3.1.1 Coronary Stent
    • 3.3.1.2 Coronary Balloon Catheter
    • 3.3.1.3 Introducer Sheath
    • 3.3.1.4 Coronary Vascular Closure Device
  • 3.3.2 Boston Scientific
    • 3.3.2.1 Coronary Stent
    • 3.3.2.2 Coronary Balloon Catheter
    • 3.3.2.3 Balloon-Inflation Device
    • 3.3.2.4 Interventional Coronary Catheter
    • 3.3.2.5 Interventional Coronary Guidewire
    • 3.3.2.6 Coronary Thrombectomy
  • 3.3.3 Cardinal Health
    • 3.3.3.1 Coronary Stent
  • 3.3.4 Medtronic
    • 3.3.4.1 Coronary Stent
    • 3.3.4.2 Introducer Sheath
    • 3.3.4.3 Coronary Balloon Catheter
    • 3.3.4.4 Interventional Coronary Catheter
  • 3.3.5 Merit Medical Systems
    • 3.3.5.1 Introducer Sheath
  • 3.3.7 Terumo
    • 3.3.7.1 Interventional Coronary Catheter
    • 3.3.7.2 Introducer Sheath
    • 3.3.7.3 Coronary Vascular Closure Device
• 3.4 CLINICAL TRIALS
  • 3.4.1 Coronary Stent
    • 3.4.1.1 Abbott
    • 3.4.1.2 Boston Scientific
    • 3.4.1.3 Medtronic
  • 3.4.2 Coronary Balloon Catheter
    • 3.4.2.1 Boston Scientific
    • 3.4.2.2 Medtronic
  • 3.4.3 Balloon Inflation Device
    • 3.4.3.1 Central Arkansas Veterans Healthcare System
    • 3.4.3.2 Guy's and St Thomas' NHS Foundation Trust
  • 3.4.4 Interventional Coronary Catheter
    • 3.4.4.1 Medtronic
    • 3.4.4.2 Philips
  • 3.4.5 Coronary Embolic Protection Device
    • 3.4.5.1 Icahan School of Medicine at Mount Sinai
    • 3.4.5.2 Javelin Medical
    • 3.4.5.3 Keystone Heart
    • 3.4.5.4 Microvention-Terumo, Inc
  • 3.4.6 Coronary Atherectomy Device
    • 3.4.6.1 Segeberger Kliniken GmbH
    • 3.4.6.2 Spectranetics Corporation
  • 3.4.7 Coronary Vascular Closure Device
    • 3.4.7.1 Cordis Corporation
    • 3.4.7.2 Medtronic
    • 3.4.7.3 Terumo Medical Corporation
  • 3.4.8 Coronary Intravascular Ultrasound
    • 3.4.8.1 Aarhhus University Hospital Skejby
    • 3.4.8.2 European Cardiovascular Research Institute
  • 3.4.9 Coronary Optical Coherence Tomography
    • 3.4.9.1 Columbia University

U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW

• 4.1 INTRODUCTION
  • 4.1.1 Population at Risk
• 4.2 MARKET OVERVIEW
• 4.3 TREND ANALYSIS BY SEGMENT
• 4.4 DRIVERS AND LIMITERS
  • 4.4.1 Market Drivers
  • 4.4.2 Market Limiters
• 4.5 COMPETITIVE MARKET SHARE ANALYSIS
• 4.6 MERGERS & ACQUISITIONS
• 4.7 COMPANY PROFILES
  • 4.7.1 Abbott
  • 4.7.2 Asahi Intecc
  • 4.7.3 Boston Scientific
  • 4.7.4 Cardinal Health
    • 4.7.4.1 Cordis (Cardinal Health)
  • 4.7.5 Cardiovascular Systems Inc.
  • 4.7.6 Cook Medical
  • 4.7.7 Medtronic
  • 4.7.8 Merit Medical Systems
  • 4.7.9 Penumbra
  • 4.7.10 Philips
  • 4.7.11 Teleflex
  • 4.7.12 Terumo
• 4.8 SWOT ANALYSIS
  • 4.8.1 Abbott
  • 4.8.2 Asahi Intecc
  • 4.8.3 Boston Scientific
  • 4.8.4 Cardinal Health
  • 4.8.5 Cardiovascular Systems Inc.
  • 4.8.6 Cook Medical
  • 4.8.7 Medtronic
  • 4.8.8 Merit Medical Systems
  • 4.8.9 Penumbra
  • 4.8.10 Philips
  • 4.8.11 Teleflex
  • 4.8.12 Terumo

IMPACT OF COVID-19 ON THE U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET

• 5.1 INTRODUCTION
  • 5.1.1 Treatable Population and the COVID-19 Virus
  • 5.1.2 Market Specifics
  • 5.1.3 United States COVID-19 Impact
• 5.2 MULTI-SCENARIO ANALYSIS
  • 5.2.1.1 Best Case Scenario
  • 5.2.1.2 Base Case Scenario
  • 5.2.1.3 Worst Case Scenario

PROCEDURE NUMBERS

• 6.1 INTRODUCTION
• 6.2 PROCEDURES OVERVIEW
  • 6.2.1 Angiography Procedures
    • 6.2.1.1 Angiography Procedures by Approach
    • 6.2.1.2 Angiography Procedures by Setting
  • 6.2.2 Angioplasty/PCI Procedures
    • 6.2.2.1 Angioplasty/PCI Procedures by Approach
    • 6.2.2.2 Angioplasty/PCI Procedures by Modality
    • 6.2.2.3 Angioplasty/PCI Procedures by Setting
    • 6.2.2.4 Angioplasty/PCI Procedures by Imaging Technique
  • 6.2.3 Coronary Atherectomy Procedures
  • 6.2.4 Catheterization Procedures

CORONARY STENT MARKET

• 7.1 INTRODUCTION
• 7.2 MARKET OVERVIEW
• 7.3 MARKET ANALYSIS AND FORECAST
  • 7.3.1 Total Coronary Stent Market
  • 7.3.2 Bare-Metal Stent Market
  • 7.3.3 Drug-Eluting Stent Market
  • 7.3.4 Covered Stent Market
  • 7.3.5 Bifurcated Stent Market
• 7.4 UNIT ANALYSIS
  • 7.4.1 Coronary Stent Units Sold by Diameter
  • 7.4.2 Coronary Stent Units Sold by Length
• 7.5 DRIVERS AND LIMITERS
  • 7.5.1 Market Drivers
  • 7.5.2 Market Limiters
• 7.6 COMPETITIVE MARKET SHARE ANALYSIS

CORONARY BALLOON CATHETER MARKET

• 8.1 INTRODUCTION
• 8.2 MARKET OVERVIEW
• 8.3 MARKET ANALYSIS AND FORECAST
  • 8.3.1 Total Coronary Balloon Catheter Market
  • 8.3.2 PTCA Balloon Catheter Market
  • 8.3.3 Total Specialty Balloon Catheter Market
    • 8.3.3.1 Cutting Balloon Catheter Market
    • 8.3.3.2 Scoring Balloon Catheter Market
• 8.4 UNIT ANALYSIS
  • 8.4.1 Coronary Balloon Catheter Units Sold by Classification
  • 8.4.2 Coronary Balloon Catheter Units Sold by Indication
• 8.5 DRIVERS AND LIMITERS
  • 8.5.1 Market Drivers
  • 8.5.2 Market Limiters
• 8.6 COMPETITIVE MARKET SHARE ANALYSIS

BALLOON-INFLATION DEVICE MARKET

• 9.1 INTRODUCTION
• 9.2 MARKET ANALYSIS AND FORECAST
• 9.3 DRIVERS AND LIMITERS
  • 9.3.1 Market Drivers
  • 9.3.2 Market Limiters
• 9.4 COMPETITIVE MARKET SHARE ANALYSIS

INTERVENTIONAL CORONARY CATHETER MARKET

• 10.1 INTRODUCTION
• 10.2 MARKET OVERVIEW
• 10.3 MARKET ANALYSIS AND FORECAST
  • 10.3.1 Total Interventional Coronary Catheter Market
  • 10.3.2 Guiding Catheter Market
  • 10.3.3 Extension Guide Catheter Market
  • 10.3.4 Micro-Catheter Market
• 10.4 DRIVERS AND LIMITERS
  • 10.4.1 Market Drivers
  • 10.4.2 Market Limiters
• 10.5 COMPETITIVE MARKET SHARE ANALYSIS

INTERVENTIONAL CORONARY GUIDEWIRE MARKET

• 11.1 INTRODUCTION
  • 11.1.1 Device Construction
• 11.2 MARKET ANALYSIS AND FORECAST
• 11.3 DRIVERS AND LIMITERS
  • 11.3.1 Market Drivers
  • 11.3.2 Market Limiters
• 11.4 COMPETITIVE MARKET SHARE ANALYSIS